Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
2022-09-23 4:18 pm Unchanged | 2022-09-15 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 83,780,600 13.410% | 0 (Unchanged) | Filing History |
2022-08-23 6:31 pm Purchase | 2022-08-19 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 83,780,600 14.320% | 1,507,790![]() (+1.83%) | Filing History |
2022-06-14 10:21 am Purchase | 2022-06-13 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 82,272,810 14.070% | 5,480,185![]() (+7.14%) | Filing History |
2022-06-09 08:00 am Purchase | 2022-06-09 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 76,792,625 13.129% | 2,220,390![]() (+2.98%) | Filing History |
2022-05-26 5:29 pm Purchase | 2022-05-26 | 13D | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 75,000,000 12.820% | 75,000,000![]() (New Position) | Filing History |
2022-02-15 12:44 pm Purchase | 2021-12-31 | 13G | Mereo BioPharma Group plc MREO | Rock Springs Capital Management LP | 5,585,621 5.130% | 5,585,621![]() (New Position) | Filing History |
2022-02-14 4:50 pm Purchase | 2021-12-31 | 13G | Mereo BioPharma Group plc MREO | Point72 Asset Management, L.P. | 10,610,000 9.100% | 3,710,331![]() (+53.78%) | Filing History |
2022-02-14 4:40 pm Sale | 2021-12-31 | 13G | Mereo BioPharma Group plc MREO | Boxer Capital LLC | 4,082,576 3.600% | -6,226,674![]() (-60.40%) | Filing History |
2022-02-14 4:16 pm Purchase | 2021-12-31 | 13G | Mereo BioPharma Group plc MREO | Baker Bros. Advisors LP | 64,917,601 9.990% | 25,285,672![]() (+63.80%) | Filing History |
2022-02-14 08:50 am Purchase | 2021-12-31 | 13G | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 74,572,235 13.700% | 18,072,235![]() (+31.99%) | Filing History |
2022-02-14 06:19 am Sale | 2021-12-31 | 13G | Mereo BioPharma Group plc MREO | Citadel Advisors LLC | 20,081,572 3.700% | -10,848,814![]() (-35.07%) | Filing History |
2022-02-11 5:26 pm Purchase | 2021-12-31 | 13G | Mereo BioPharma Group plc MREO | Vivo Capital IX, LLC | 9,409,051 7.800% | 448,755![]() (+5.01%) | Filing History |
2022-02-11 4:37 pm Purchase | 2021-12-31 | 13G | Mereo BioPharma Group plc MREO | Suvretta Capital Management, LLC | 45,710,335 8.400% | 13,882,835![]() (+43.62%) | Filing History |
2022-02-11 4:31 pm Purchase | 2021-12-31 | 13G | Mereo BioPharma Group plc MREO | ORBIMED ADVISORS LLC | 6,063,345 5.590% | 1,544,989![]() (+34.19%) | Filing History |
2021-12-02 2:31 pm Purchase | 2021-09-30 | 13G | Mereo BioPharma Group plc MREO | Rubric Capital Management LP | 56,500,000 10.380% | 56,500,000![]() (New Position) | Filing History |
2021-03-01 5:19 pm Purchase | 2021-02-17 | 13G | Mereo BioPharma Group plc MREO | Point72 Asset Management, L.P. | 6,899,669 6.400% | 6,899,669![]() (New Position) | Filing History |
2021-02-19 4:27 pm Purchase | 2021-02-10 | 13G | Mereo BioPharma Group plc MREO | Suvretta Capital Management, LLC | 31,827,500 5.900% | 31,827,500![]() (New Position) | Filing History |
2021-02-16 4:53 pm Purchase | 2020-12-31 | 13G | Mereo BioPharma Group plc MREO | Baker Bros. Advisors LP | 39,631,929 11.400% | 39,631,929![]() (New Position) | Filing History |
2021-02-16 4:30 pm Sale | 2020-12-31 | 13G | Mereo BioPharma Group plc MREO | Vivo Capital IX, LLC | 8,960,296 8.168% | -21,635,328![]() (-70.71%) | Filing History |
2021-02-16 4:30 pm Sale | 2020-12-31 | 13G | Mereo BioPharma Group plc MREO | Citadel Advisors LLC | 30,930,386 8.900% | -202,605![]() (-0.65%) | Filing History |